Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
DeepCure
AddedFeb 17, 2024
UpdatedJun 18, 2026
DeepCure

DeepCure

Series A

DeepCure: Accelerating affordable AI-powered drug discovery for better, faster results.

HQ
Boston, MA, US
Founded
2018
Overview
Compare
Fundraising
Employees
Website

DeepCure, founded with the mission to revolutionize small-molecule drug discovery, leverages advanced AI technology to deliver more effective drugs faster and at a lower cost. The company focuses on transforming the pharmaceutical industry by integrating cutting-edge robotics and artificial intelligence to streamline and enhance the drug development process. DeepCure aims to make high-quality treatments more accessible and affordable, addressing critical healthcare needs globally.

Notable figures associated with DeepCure include a distinguished leadership team and a robust scientific advisory board comprising experts in AI and drug discovery. The company has attracted significant investment from prominent venture capital firms, underscoring its potential impact. Key achievements include the development of a sophisticated AI-driven platform that accelerates the identification and optimization of therapeutic candidates. DeepCure's innovative approach has positioned it as a leader in the biotech industry, promising substantial advancements in patient care and treatment efficacy.

DeepCure - Similar Companies

Deep Apple Therapeutics logo

Deep Apple Therapeutics

deepappletx.com

Cognaisent logo

Cognaisent

cognaisent.com

Immunocure Discovery Solutions logo

Immunocure Discovery Solutions

immunocure.us

DeepBiome Therapeutics logo

DeepBiome Therapeutics

Insitro logo

Insitro

insitro.com

Atomic AI logo

Atomic AI

atomic.ai

Terray Therapeutics logo

Terray Therapeutics

terraytx.com

Biosim logo

Biosim

TandemAI logo

TandemAI

tandemai.com

Aureka Biotechnologies logo

Aureka Biotechnologies

aurekabio.com

Zephyr AI logo

Zephyr AI

zephyrai.bio

Curie.Bio logo

Curie.Bio

curie.bio

Celeris Therapeutics logo

Celeris Therapeutics

celeristx.com

Model Medicines logo

Model Medicines

modelmedicines.com

AMPLY Discovery logo

AMPLY Discovery

amplydiscovery.com

DeepCure - Quick Facts

Who are DeepCure's competitors?

Companies similar to DeepCure include Deep Apple Therapeutics, Cognaisent, Immunocure Discovery Solutions and DeepBiome Therapeutics.

When was DeepCure founded?

DeepCure was founded in 2018.

Where is DeepCure's headquarters located?

DeepCure's headquarters is located in Boston, MA, US.

When was DeepCure's last funding round?

DeepCure's most recent funding round was for $40M (USD) in November 2021.

How much has DeepCure raised to-date?

As of Nov 8, 2021, DeepCure has raised a total of $40M (USD).

How many employees does DeepCure have?

DeepCure has 39 employees as of Feb 4, 2024.

DeepCure - Classification

Ownership
  • Venture Capital
Technology
  • AI
  • Machine Learning
Geographic Exposure
  • Global
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Discovery
Tags
  • Biotech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 5 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 7372Prepackaged Software